Want to see HK:6186 full AI Analyst Report?
6186 Stock Chart & Stats
HK$2.94
HK$0.02(0.62%)
At close: 4:00 PM EDT
HK$2.94
HK$0.02(0.62%)
Day’s Range― - ―
52-Week RangeHK$2.44 - HK$4.48
Previous CloseN/A
Volume18.36M
Average Volume (3M)21.94M
Market Cap
HK$22.87B
Enterprise ValueHK$9.55K
Total Cash (Recent Filing)HK$15.39B
Total Debt (Recent Filing)HK$541.21M
Price to Earnings (P/E)11.2
Beta0.61
Next Earnings
Apr 01, 2027EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend Yield8.24%
Share Statistics
EPS (TTM)0.20
Shares Outstanding9,067,252,000
10 Day Avg. Volume29,581,586
30 Day Avg. Volume21,936,108
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)1.35
Price to Sales (P/S)1.82
P/FCF Ratio51.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$3.52Price Target Upside19.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.22
Revenue Forecast (FY)HK$18.42B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and substantial equity backing provide financial resilience through operating volatility. The conservative capital structure should preserve flexibility to fund products, marketing, and operations internally while reducing the pressure that debt service can place on cash flow.
Strong Gross MarginA gross margin near 65% indicates that the branded nutrition portfolio retains meaningful product economics despite weaker earnings. This margin base can support continued investment in research, product positioning, and distribution, provided revenue and cost pressures stabilize.
Vertical Integration And Branded ModelThe combination of branded infant nutrition products, formulation and R&D, and operational control over sourcing and production can support quality consistency and cost management. These capabilities provide a durable foundation for maintaining consumer trust and branded-product margins.
Bears Say
Revenue ContractionThe sharp 2025 revenue decline signals weaker demand, distribution, product mix, or other commercial conditions in the company’s core nutrition business. If the contraction persists, lower scale could reduce operating leverage and make it harder to sustain investment and market position.
Margin CompressionThe substantial decline in net margin shows that profitability has weakened well beyond the revenue trend. Persistent compression would reduce earnings resilience and limit the company’s ability to convert its strong gross-margin profile into durable returns for reinvestment or shareholders.
Weakening Cash ConversionThe steep fall in free cash flow and conversion from earnings indicates that reported profitability is producing materially less cash. Continued weakness could constrain internally funded growth, dividends, or strategic investment even though the balance sheet remains conservatively financed.
China Feihe Limited News
6186 FAQ
What was China Feihe Limited’s price range in the past 12 months?
China Feihe Limited lowest stock price was HK$2.44 and its highest was HK$4.48 in the past 12 months.
What is China Feihe Limited’s market cap?
China Feihe Limited’s market cap is HK$22.87B.
When is China Feihe Limited’s upcoming earnings report date?
China Feihe Limited’s upcoming earnings report date is Apr 01, 2027 which is in 187 days.
How were China Feihe Limited’s earnings last quarter?
China Feihe Limited released its earnings results on Aug 26, 2026. The company reported HK$0.105 earnings per share for the quarter, missing the consensus estimate of HK$0.164 by -HK$0.058.
Is China Feihe Limited overvalued?
According to Wall Street analysts China Feihe Limited’s price is currently Undervalued.
Does China Feihe Limited pay dividends?
China Feihe Limited pays a Semiannually dividend of HK$0.083 which represents an annual dividend yield of 8.24%. See more information on China Feihe Limited dividends here
What is China Feihe Limited’s EPS estimate?
China Feihe Limited’s EPS estimate is 0.12.
How many shares outstanding does China Feihe Limited have?
China Feihe Limited has 9,067,252,000 shares outstanding.
What happened to China Feihe Limited’s price movement after its last earnings report?
China Feihe Limited reported an EPS of HK$0.105 in its last earnings report, missing expectations of HK$0.164. Following the earnings report the stock price went up 1.538%.
Which hedge fund is a major shareholder of China Feihe Limited?
Currently, no hedge funds are holding shares in HK:6186
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Feihe Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.02%
12-Months-Change
Fundamentals
Return on Equity
8.24%
Trailing 12-Months
Asset Growth
7.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
China Feihe Limited
China Feihe Limited operates as an investment holding entity primarily engaged in the production and sale of infant formula, serving consumers across Mainland China and the United States. Its comprehensive product portfolio extends to include raw and liquid milk, adult milk powders, various healthcare products, and specialized powders like soybean and goat milk. Furthermore, the company retails vitamins, minerals, herbal supplements, and other nutritional items. Products reach consumers through a multi-channel approach, utilizing third-party distributors, prominent e-commerce platforms such as Tmall, JD.com, and Suning.com, alongside its official website and mobile applications, including WeChat. By December 31, 2021, its extensive distribution network involved approximately 2,000 offline customers, managing 110,000 retail points of sale. China Feihe Limited was established in 1962 and is headquartered in Beijing, People's Republic of China.
6186 Stock 12 Month Forecast
Average Price Target
HK$3.52
▲(19.84% Upside)
Technical Analysis
Want Want China Holdings
―
Health and Happiness (H&H) International Holdings
―
China Mengniu Dairy Co
―
Vitasoy International Holdings
―
Ausnutria Dairy Corp. Ltd.
―






